Enlivex Ltd. Company Profile
NASDAQ: ENLVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.255 +0.39%
Enlivex at a glance
Enlivex Ltd. (NASDAQ: ENLV) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Ness Ziona, Israel. Enlivex is led by Dr. Oren Hershkovitz Ph.D. and employs about 34 people. The company's shares have traded publicly since 2014.
At a market capitalization of $5.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001596812, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Enlivex do?
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Enlivex Ltd.
- Ticker
- NASDAQ: ENLV
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Oren Hershkovitz Ph.D.
- Employees
- 34
- Headquarters
- 14 Einstein Street, Ness Ziona, Israel
- Phone
- 972 2 620 8072
- Website
- enlivex.com
- IPO year
- 2014
- Market cap
- $5.51M
- SEC CIK
- 0001596812
Companies similar to Enlivex
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LNAILunai Bioworks Inc. | 1.23 | +9.82% | $5.58M | vs ENLV |
| GELSGelteq Limited | 0.5212 | -5.03% | $5.58M | vs ENLV |
| BGMSBio Green Med Solution Inc. | 0.849 | +3.41% | $5.62M | vs ENLV |
| ADXNAddex Therapeutics Ltd ADR | 3.22 | +1.21% | $5.64M | vs ENLV |
| KALAKALA BIO Inc. | 0.2939 | -0.91% | $5.68M | vs ENLV |
| PULMPulmatrix Inc. | 1.46 | -4.39% | $5.33M | vs ENLV |
| CANFCan-Fite Biopharma Ltd ADR | 1.90 | -5.00% | $5.76M | vs ENLV |
| DRMADermata Therapeutics Inc. | 1.02 | -4.67% | $5.05M | vs ENLV |